DNER and melanoma: Like NGFRHigh melanoma cells, DTPs are sensitive to some kinase inhibitors and to inhibitors of epigenome‐modifying enzymes, HDACs in the case of DTPs, and BET inhibitors in the case of vemurafenib‐adapted melanoma cells.